Cargando…
Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath
Introduction: We studied the trend of antimicrobial resistance and consumption at Saint George Hospital University Medical Center (SGHUMC), a tertiary care center in Beirut, Lebanon, with a focus on the SARS-CoV-2 pandemic. Materials and Methods: We calculated the isolation density/1000 patient-days...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388970/ https://www.ncbi.nlm.nih.gov/pubmed/34439065 http://dx.doi.org/10.3390/antibiotics10081016 |
_version_ | 1783742755327967232 |
---|---|
author | Chamieh, Amanda Zgheib, Rita El-Sawalhi, Sabah Yammine, Laure El-Hajj, Gerard Zmerli, Omar Afif, Claude Rolain, Jean-Marc Azar, Eid |
author_facet | Chamieh, Amanda Zgheib, Rita El-Sawalhi, Sabah Yammine, Laure El-Hajj, Gerard Zmerli, Omar Afif, Claude Rolain, Jean-Marc Azar, Eid |
author_sort | Chamieh, Amanda |
collection | PubMed |
description | Introduction: We studied the trend of antimicrobial resistance and consumption at Saint George Hospital University Medical Center (SGHUMC), a tertiary care center in Beirut, Lebanon, with a focus on the SARS-CoV-2 pandemic. Materials and Methods: We calculated the isolation density/1000 patient-days (PD) of the most isolated organisms from 1 January 2015–31 December 2020 that included: E. coli (Eco), K. pneumoniae (Kp), P. aeruginosa (Pae), A. baumannii (Ab), S. aureus (Sau), and E. faecium (Efm). We considered March–December 2020 a surrogate of COVID-19. We considered one culture/patient for each antimicrobial susceptibility and excluded Staphylococcus epidermidis, Staphylococcus coagulase-negative, and Corynebacterium species. We analyzed the trends of the overall isolates, the antimicrobial susceptibilities of blood isolates (BSI), difficult-to-treat (DTR) BSI, carbapenem-resistant Enterobacteriaceae (CRE) BSI, and restricted antimicrobial consumption as daily-defined-dose/1000 PD. DTR implies resistance to carbapenems, beta-lactams, fluoroquinolones, and additional antimicrobials where applicable. Results and Discussion: After applying exclusion criteria, we analyzed 1614 blood cultures out of 8314 cultures. We isolated 85 species, most commonly Eco, at 52%. The isolation density of total BSI in 2020 decreased by 16%: 82 patients were spared from bacteremia, with 13 being DTR. The isolation density of CRE BSI/1000 PD decreased by 64% from 2019 to 2020, while VREfm BSI decreased by 34%. There was a significant decrease of 80% in Ab isolates (p-value < 0.0001). During COVID-19, restricted antimicrobial consumption decreased to 175 DDD/1000 PD (p-value < 0.0001). Total carbapenem consumption persistently decreased by 71.2% from 108DDD/1000 PD in 2015–2019 to 31 DDD/1000 PD in 2020. At SGHUMC, existing epidemics were not worsened by the pandemic. We attribute this to our unique and dynamic collaboration of antimicrobial stewardship, infection prevention and control, and infectious disease consultation. |
format | Online Article Text |
id | pubmed-8388970 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83889702021-08-27 Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath Chamieh, Amanda Zgheib, Rita El-Sawalhi, Sabah Yammine, Laure El-Hajj, Gerard Zmerli, Omar Afif, Claude Rolain, Jean-Marc Azar, Eid Antibiotics (Basel) Article Introduction: We studied the trend of antimicrobial resistance and consumption at Saint George Hospital University Medical Center (SGHUMC), a tertiary care center in Beirut, Lebanon, with a focus on the SARS-CoV-2 pandemic. Materials and Methods: We calculated the isolation density/1000 patient-days (PD) of the most isolated organisms from 1 January 2015–31 December 2020 that included: E. coli (Eco), K. pneumoniae (Kp), P. aeruginosa (Pae), A. baumannii (Ab), S. aureus (Sau), and E. faecium (Efm). We considered March–December 2020 a surrogate of COVID-19. We considered one culture/patient for each antimicrobial susceptibility and excluded Staphylococcus epidermidis, Staphylococcus coagulase-negative, and Corynebacterium species. We analyzed the trends of the overall isolates, the antimicrobial susceptibilities of blood isolates (BSI), difficult-to-treat (DTR) BSI, carbapenem-resistant Enterobacteriaceae (CRE) BSI, and restricted antimicrobial consumption as daily-defined-dose/1000 PD. DTR implies resistance to carbapenems, beta-lactams, fluoroquinolones, and additional antimicrobials where applicable. Results and Discussion: After applying exclusion criteria, we analyzed 1614 blood cultures out of 8314 cultures. We isolated 85 species, most commonly Eco, at 52%. The isolation density of total BSI in 2020 decreased by 16%: 82 patients were spared from bacteremia, with 13 being DTR. The isolation density of CRE BSI/1000 PD decreased by 64% from 2019 to 2020, while VREfm BSI decreased by 34%. There was a significant decrease of 80% in Ab isolates (p-value < 0.0001). During COVID-19, restricted antimicrobial consumption decreased to 175 DDD/1000 PD (p-value < 0.0001). Total carbapenem consumption persistently decreased by 71.2% from 108DDD/1000 PD in 2015–2019 to 31 DDD/1000 PD in 2020. At SGHUMC, existing epidemics were not worsened by the pandemic. We attribute this to our unique and dynamic collaboration of antimicrobial stewardship, infection prevention and control, and infectious disease consultation. MDPI 2021-08-21 /pmc/articles/PMC8388970/ /pubmed/34439065 http://dx.doi.org/10.3390/antibiotics10081016 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chamieh, Amanda Zgheib, Rita El-Sawalhi, Sabah Yammine, Laure El-Hajj, Gerard Zmerli, Omar Afif, Claude Rolain, Jean-Marc Azar, Eid Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath |
title | Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath |
title_full | Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath |
title_fullStr | Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath |
title_full_unstemmed | Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath |
title_short | Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015–2020: COVID-19 Aftermath |
title_sort | trends of multidrug-resistant pathogens, difficult to treat bloodstream infections, and antimicrobial consumption at a tertiary care center in lebanon from 2015–2020: covid-19 aftermath |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388970/ https://www.ncbi.nlm.nih.gov/pubmed/34439065 http://dx.doi.org/10.3390/antibiotics10081016 |
work_keys_str_mv | AT chamiehamanda trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath AT zgheibrita trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath AT elsawalhisabah trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath AT yamminelaure trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath AT elhajjgerard trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath AT zmerliomar trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath AT afifclaude trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath AT rolainjeanmarc trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath AT azareid trendsofmultidrugresistantpathogensdifficulttotreatbloodstreaminfectionsandantimicrobialconsumptionatatertiarycarecenterinlebanonfrom20152020covid19aftermath |